This inventor holds 38 USPTO granted patents and 4 published patent applications and 12 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Merck Frosst Canada, Inc.. Active years: 1999-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edison, NJ (US) (1999 - 2001)
- Scotch Plains, NJ (US) (2004 - 2015)
- Kenilworth, NJ (US) (2019)
- Ridgewood, NJ (US) (2019)
- Hoboken, NJ (US) (2018 - 2021)
Company Filing History:
23 out of 4,770 
15 out of 2,405 
1 out of 212 
Years Active: 1999-2021
Areas of Expertise:
Title: Feroze Ujjainwalla: Pioneering Innovations in Pharmaceutical Chemistry
Introduction: Feroze Ujjainwalla, based in Scotch Plains, New Jersey, is a prolific inventor known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 38 patents, he has played a crucial role in developing innovative compounds aimed at treating various diseases and conditions, particularly those related to metabolic disorders and cancer.
Latest Patents: Among his latest innovations are two notable patents: the first involves substituted tetrahydroisoquinoline compounds identified as useful agonists of the G-protein coupled receptor GPR120. These compounds, along with their pharmaceutically acceptable salts, present a promising approach to treating or preventing diabetes, hyperlipidemia, obesity, non-alcoholic steatohepatitis (NASH), and various inflammation-related disorders. The second patent focuses on tricyclic compounds as inhibitors of mutant IDH enzymes. These compounds may offer potential treatment options for cancers associated with mutant IDH enzymes, along with compositions that harness their therapeutic properties.
Career Highlights: Feroze Ujjainwalla's career includes significant tenures at prominent companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation, where he has been instrumental in advancing research and development efforts. His commitment to innovation in pharmaceuticals has made an impactful difference in healthcare.
Collaborations: Throughout his career, Ujjainwalla has had the opportunity to collaborate with esteemed colleagues like Thomas F. Walsh and Mark T. Goulet. These partnerships have likely contributed to the fruitful results seen in his prolific patent portfolio.
Conclusion: Feroze Ujjainwalla stands out as a distinguished inventor in the field of pharmaceutical science. His dedication to innovation and his successful patents reflect his important role in advancing treatments for diseases that affect countless individuals worldwide. As he continues to contribute to the industry, his work may lead to more groundbreaking discoveries in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile